TY - JOUR T1 - FGF signaling in development beyond canonical pathways JF - bioRxiv DO - 10.1101/2020.05.13.093252 SP - 2020.05.13.093252 AU - Ayan T. Ray AU - Pierre Mazot AU - J. Richard Brewer AU - Catarina Catela AU - Colin J. Dinsmore AU - Philippe Soriano Y1 - 2020/01/01 UR - http://biorxiv.org/content/early/2020/07/01/2020.05.13.093252.abstract N2 - FGFs are key developmental regulators which engage a signal transduction cascade through receptor tyrosine kinases, typically involving ERK1/2, PI3K/AKT, and other effectors. However, it remains unknown if all FGF activities depend on kinase activity or these canonical signal transduction cascades. To address these questions, we generated allelic series of knock-in Fgfr1 and Fgfr2 mouse strains, carrying point mutations that disrupt binding of signaling effectors to the receptors, alone or in combination. We also produced a kinase dead allele of Fgfr2 which broadly phenocopies the null mutant. When interrogated in cranial neural crest cells, point mutations in either receptor revealed discrete functions for signaling pathways in specific craniofacial contexts, but failed to recapitulate the single or double null mutant phenotypes even in their most extensive combination. Furthermore, we found that together these signaling mutations abrogated the established FGF-induced signal transduction pathways, yet certain FGF functions such as cell-matrix and cell-cell adhesion remained unaffected. Our studies establish combinatorial roles of both Fgfr1 and Fgfr2 in development and identify novel kinase-dependent cell adhesion properties of FGF receptors, independent of well-established roles in intracellular signaling.Competing Interest StatementThe authors have declared no competing interest. ER -